SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

THE ANGEL–(BUSINESS WIRE) – Schall law firm, a national law firm specializing in shareholder rights, is reminding investors of a class action lawsuit filed against Repro Med Systems, Inc. against KORU Medical Systems (“KURO” or “the Company”) (NASDAQ: KRMD) for violations of Section 10 ( b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b-5 issued by the US Securities and Exchange Commission.

Investors who purchased the Company’s securities between August 4, 2020 and January 25, 2021 (including the “Class Period”) are requested to contact the Company before May 25, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights at no charge. You can also contact us on the company’s website at www.schallfirm.com or by email at brian@schallfirm.com.

In this case, the class has not yet been certified and you will not be represented by a lawyer until certification. If you don’t take action, you can remain an absent class member.

According to the complaint, the company made false and misleading statements to the market. KORU increased the use of allowances such as key customer growth discounts to keep their business going and improve growth from January 2020. As these discounts increased, the company’s net sales were likely to decline. Because of these facts, the company’s public statements were false and materially misleading throughout the teaching period. When the market learned the truth about KORU, investors suffered damage.

Join the case to make up for your losses.

Schall law firm represents investors around the world and specializes in class action and shareholder disputes.

This press release may be viewed as a solicitor’s advertisement in some jurisdictions under applicable laws and ethical rules.

Comments are closed.